Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-042899
Filing Date
2011-08-03
Accepted
2011-08-03 08:39:12
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-13935_110q.htm 10-Q 2763565
2 EX-31.1 a11-13935_1ex31d1.htm EX-31.1 12438
3 EX-31.2 a11-13935_1ex31d2.htm EX-31.2 12539
4 EX-32.1 a11-13935_1ex32d1.htm EX-32.1 4979
5 EX-32.2 a11-13935_1ex32d2.htm EX-32.2 5334
  Complete submission text file 0001104659-11-042899.txt   15574006

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ceph-20110630.xml EX-101.INS 2700230
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ceph-20110630.xsd EX-101.SCH 89606
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ceph-20110630_cal.xml EX-101.CAL 99918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ceph-20110630_def.xml EX-101.DEF 401842
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ceph-20110630_lab.xml EX-101.LAB 1200089
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ceph-20110630_pre.xml EX-101.PRE 543993
Mailing Address 41 MOORES ROAD FRAZER PA 19355
Business Address 41 MOORES ROAD FRAZER PA 19355 6103440200
CEPHALON INC (Filer) CIK: 0000873364 (see all company filings)

EIN.: 232484489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19119 | Film No.: 111005392
SIC: 2834 Pharmaceutical Preparations